His Experience with Dupuytren’s Contracture Led Him to Launch a Venture to Advance Treatment
source: pixabay.com

His Experience with Dupuytren’s Contracture Led Him to Launch a Venture to Advance Treatment

It all began at a movie theater. Kurt Harrington and his father were leaving the theater when his father decided to hold the door open for some others. Someone knocked…

Continue Reading His Experience with Dupuytren’s Contracture Led Him to Launch a Venture to Advance Treatment
Rare Community Profiles: This Rare Family is Managing CVID, MS, UC, and Double Cortex Syndrome: Here’s How You Can Help
source: shutterstock.com

Rare Community Profiles: This Rare Family is Managing CVID, MS, UC, and Double Cortex Syndrome: Here’s How You Can Help

Rare Community Profiles   Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their families,…

Continue Reading Rare Community Profiles: This Rare Family is Managing CVID, MS, UC, and Double Cortex Syndrome: Here’s How You Can Help
Rare Community Profiles: CureDuchenne Clinic in Greater Dallas Area Aims to Improve Treatment Accessibility and Care for Underserved Families with DMD and BMD
source: shutterstock.com

Rare Community Profiles: CureDuchenne Clinic in Greater Dallas Area Aims to Improve Treatment Accessibility and Care for Underserved Families with DMD and BMD

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: CureDuchenne Clinic in Greater Dallas Area Aims to Improve Treatment Accessibility and Care for Underserved Families with DMD and BMD
Washington State Recognizes Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorder Awareness Month
source: shutterstock.com

Washington State Recognizes Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorder Awareness Month

Written by Carter Hemion On April 17, 2023, Governor Inslee signed a ceremonial proclamation recognizing May as Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorder Awareness month in Washington State. The International…

Continue Reading Washington State Recognizes Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorder Awareness Month
Rare Community Profiles: Dr. Jonathan Barratt Discusses Phase 2b Data on Atacicept for IgA Nephropathy
source: shutterstock.com

Rare Community Profiles: Dr. Jonathan Barratt Discusses Phase 2b Data on Atacicept for IgA Nephropathy

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: Dr. Jonathan Barratt Discusses Phase 2b Data on Atacicept for IgA Nephropathy
Study of the Week: Researchers Identify Racial and Socioeconomic Disparities in Pediatric Bone Cancer Outcomes
source: pixabay.com

Study of the Week: Researchers Identify Racial and Socioeconomic Disparities in Pediatric Bone Cancer Outcomes

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Researchers Identify Racial and Socioeconomic Disparities in Pediatric Bone Cancer Outcomes
Blinatumomab Immunotherapy is Effective for Infants with Aggressive Acute Lymphoblastic Leukemia (ALL)
192635 / Pixabay

Blinatumomab Immunotherapy is Effective for Infants with Aggressive Acute Lymphoblastic Leukemia (ALL)

  KMT2A rearrangements—a DNA fault—lead to treatment-resistant acute lymphoblastic leukemia (ALL) in infants. While around 50% of children with KMT2A rearrangements respond well to intensive chemotherapy, the remaining 50% do…

Continue Reading Blinatumomab Immunotherapy is Effective for Infants with Aggressive Acute Lymphoblastic Leukemia (ALL)
May is Cystic Fibrosis (CF) Month and Some Patients Are Living Past Middle Age Due to Treatment Advances
source: pixabay.com

May is Cystic Fibrosis (CF) Month and Some Patients Are Living Past Middle Age Due to Treatment Advances

There is no cure for cystic fibrosis. That is the reason the Cystic Fibrosis Research Institute (CFRI) is very vocal and makes it clear that cooperation is needed from the…

Continue Reading May is Cystic Fibrosis (CF) Month and Some Patients Are Living Past Middle Age Due to Treatment Advances